Your browser doesn't support javascript.
loading
Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?
Huibers, Minke; Abla, Oussama; Andrés, Mara; Balagué, Olga; Beishuizen, Auke; Carraro, Elisa; Chiang, Alan; Csóka, Monika; David, Bianca-Andreea; de Ville de Goyet, Maëlle; Gilad, Gil; Hori, Daiki; Kotecha, Rishi S; Kabickova, Edita; Klapper, Wolfram; Miakova, Natasha; Minard-Colin, Veronique; Nakazawa, Atsuko; Pillon, Marta; Rigaud, Charlotte; Salaverria, Itziar; Tölle, Ida; Verdú-Amorós, Jaime; von Mersi, Hannah; Wössmann, Wilhelm; Burkhardt, Birgit; Attarbaschi, Andishe.
Afiliação
  • Huibers M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Abla O; Division of Hematology and Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, Canada.
  • Andrés M; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.
  • Balagué O; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Carraro E; Maternal and Child Health Department, Pediatric Hematology, Oncology and Stem Cell Transplant Center, University of Padova, Padova, Italy.
  • Chiang A; Department of Paediatrics & Adolescent Medicine, The University of Hong Kong, Hong Kong.
  • Csóka M; Pediatric Clinic (Tuzoltó Street Department), Semmelweis University, Budapest, Hungary.
  • David BA; Department of Pediatric Hematology and Oncology, Department of Pediatrics, University Hospital Liège, Liège, Belgium.
  • de Ville de Goyet M; Department of Pediatric Hematology and Oncology, Cliniques universitaires Saint-Luc, UC Louvain, Brussels, Belgium.
  • Gilad G; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center, Petah Tikva, and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hori D; Department of Hematology and Oncology for children and adolescents, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Kotecha RS; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Australia.
  • Kabickova E; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • Klapper W; Curtin Medical School, Curtin University, Perth, Australia.
  • Miakova N; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
  • Minard-Colin V; Hematopathology Section, Department of Pathology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Nakazawa A; Department of Pediatric Hematology and Oncology, Federal Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
  • Pillon M; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France.
  • Rigaud C; Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan.
  • Salaverria I; Hematopathology section, Pathology Department, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
  • Tölle I; Department of Pediatric and Adolescent Oncology, Gustave-Roussy Cancer Campus, Paris-Sacaly University, Villejuif, France.
  • Verdú-Amorós J; Department of Pathology, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • von Mersi H; Pediatric Hematology and Oncology and NHL-BFM Study Center, University Hospital Münster, Münster, Germany.
  • Wössmann W; Department of Pediatric Hematology and Oncology, University Hospital La Fe of Valencia, Valencia, Spain.
  • Burkhardt B; Department of Pediatric Hematology and Oncology, Hospital Clínico Universitario, Biomedical Research Institute, INCLIVA, Valencia, Spain.
  • Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
Blood Adv ; 8(6): 1509-1514, 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38290136
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Adolescent / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Limite: Adolescent / Child / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article